Quick Listen: Scrip’s Five Must-Know Things
In this week's episode: Trump’s UK drug pricing win; Novo explains semaglutide Alzheimer's rationale; J&J and Novartis on this year’s biggest M&A deals; a look at the mixed performance of CAR-Ts; and Akeso’s goals beyond ivonescimab.
Scrip - December 8, 2025

CorWave Ready To Dive Into LVAD Market Following First-In-Human Study
The French start-up has successfully implanted its ‘fishtail’ LVAD in a patient for 84 days, where it served as an effective bridge to transplant. Medtech Insight spoke to the company’s CEO, Louis de Lillers, to hear more about the company’s progress and his take on the evolving LVAD market.
Medtech Insight - December 5, 2025

Olympus Hits Another Endoscope Snag, Updates Instructions For PolyLoop After 113 Serious Injuries
The US FDA says Olympus has updated its instructions for a device used in many endoscopic procedures after reports of serious injuries. The class I recall follows the FDA blocking imports of other scoping devices from the Japanese firm earlier this year.
Medtech Insight - December 5, 2025

Medtronic’s Hugo RAS Gets FDA Nod For Urologic Procedures, But Intuitive Still Leads, Analyst Says
Medtronic won FDA clearance for its Hugo surgical robot for urologic procedures, which Wiliam Blair analyst expects will draw interest from physicians. But he also says that Intuitive Surgical will remain the clear dominant player.
Medtech Insight - December 5, 2025

NICE Rules-Based Pathway Tops Conference Talking Points For UK Healthtechs
Digital technology and AI have pushed healthcare delivery to a transformational turning point, but market access, budget constraints and scaling adoption of innovation remain the eternal challenges for healthtech manufacturers.
Medtech Insight - December 5, 2025

US FDA Advisory Committees: Analysis Finds Most Public Hearing Speakers Favor Approval
The tilt toward approval extended beyond patients and advocates to clinicians, professional societies and industry.
HBW Insight - December 8, 2025

Two Strikes And Firms Selling 7-OH Supplements Will Be Out Of Options To Avoid US Enforcement
Enforcements at facilities in Missouri operated by Shaman Botanicals and Relax Relief Rejuvenate Trading were preceded by administrative detention orders, FDA’s first use of the authority since its reorganization in October 2024.
HBW Insight - December 8, 2025

Formycon Delivers On Keytruda Biosimilar Partnership Promise With MS Pharma Deal
While the long-awaited pembrolizumab biosimilar deal certainly boosts Formycon’s financials, it is unclear whether it will be enough to meet its annual guidance.
Generics Bulletin - December 5, 2025

Fresenius Kabi Adopts AI To Optimize Biosimilar And Antibody Manufacturing
Partnership aims to improve yields, cut development time, and bring data-driven control to bioprocessing.
Generics Bulletin - December 5, 2025

Scrip 100: Double-Digit Growth Propels Leaderboard Gainers
AstraZeneca, Lilly, Novo Nordisk and Amgen all moved up in the rankings on the Scrip 100 leaderboard powered by impressive double-digit growth.
In Vivo - December 4, 2025